NorthWest Biotherapeutics Inc (NWBO): Agreed GGB. Merck currently has ~$10.5B...

Reply Private New

Replies (2) Next 10 Prev Next

Send PM Follow Ignore

Followers	88
Posts	1170
Boards Moderated	0
Alias Born	09/10/2017

hyperopia

Re: GoodGuyBill post# 271648

Wednesday, 03/18/2020 1:17:03 PM

Wednesday, March 18, 2020 1:17:03 PM

Agreed GGB. Merck currently has ~$10.5B cash on hand, and last month announced a spinoff of women’s health, some slower-growth legacy brands, and biosimilars products into a new company to be named later. Merck expects to receive $8B to $9B through a special tax-free dividend from the NewCo., and expects that these funds will be allocated to business development, or share repurchases.

MERCK 4Q & 2019 FULL-YEAR EARNINGS SPINOFF OF NEWCO

https://s21.q4cdn.com/488056881/files/doc_financials/2019/q4/4Q19-Earnings-Deck_MRK.pdf

For example, Merck would not have a financial resource issue as it is a $200B company that has not been significantly affected by the current market disruption. Hell Merck could sell older (but still financially stable) products and use the money to partner with a protected, cash-cow product dcvax. In fact, I believe Merck has sold a number of smaller units, accumulating cash? For DCVax partnership?